ArticleParasites & vectors2025
Ostertagia ostertagi exposure in dairy cows in the alpine space: implications for region-specific assessments.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fasciola hepatica in alpine dairy farming: prevalence trends, risk factors and associations with Salmonella Dublin seropositivity.BMC veterinary research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPasture-based management of dairy cattle in temperate regions leads to infections with gastrointestinal nematodes, with Ostertagia ostertagi recognised as the most pathogenic species of these. However, little is known about O. ostertagi exposure in alpine regions. Here, we aimed to explore the O. ostertagi seropositivity in a large sample of dairy cows from two Austrian federal states that differ substantially in herd size, productivity and use of (alpine) pastures, and to assess associations between parasite exposure, milk yield, and farm management factors.
methodsBulk tank milk (BTM) samples from 1241 dairy farms in the federal states of Upper Austria (n = 742) and Tyrol (n = 499), of which the dairy herds comprised a total of 25,985 adult cows, were analysed for anti-O. ostertagi immunoglobulin G at the end of the grazing season 2018. Anti-Ostertagia antibody levels in milk [measured as the optical density (OD) ratio (ODR)] from herds with known grazing were evaluated for associations with production and management data via linear models to (1) evaluate the effect of farm management practices on herd exposure to O. ostertagi, and (2) assess the association of O. ostertagi exposure and management practices with milk production.
resultsOf all the investigated herds, 65.3% were positive for O. ostertagi infections (ODR ≥ 0.5), with a mean ODR of 0.59 (25th-75th percentile 0.42-0.75). Herds in Tyrol had higher mean BTM-ODR values (0.73; 25th-75th percentile 0.61-0.87) than those in Upper Austria (0.50; 0.38-0.63); however, alpine grazing was not associated with higher ODR values in either Austrian state. In Upper Austria, organic farming was significantly associated with higher O. ostertagi exposure, whereas in Tyrol, larger herd sizes were linked to increased exposure. Lower milk yield was significantly associated with decreasing cow herd size and organic farming in both federal states, but not with increasing O. ostertagi ODR.
conclusionsMarked differences in the exposure of Austrian dairy cattle to O. ostertagi are likely explained by contrasting grazing management between the investigated states and by specific characteristics of each region. No association between increased parasite exposure and milk yield was observed, highlighting the need for region-specific investigations. Small-scale and/or alpine cattle farming with predominantly dual-purpose breeds requires a tailored risk assessment to support sustainable parasite control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.